Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun 5;6(3):301-319.
doi: 10.1002/open.201700051. eCollection 2017 Jun.

Synthetic Approaches toward Monocyclic 3-Amino-β-lactams

Affiliations
Review

Synthetic Approaches toward Monocyclic 3-Amino-β-lactams

Sari Deketelaere et al. ChemistryOpen. .

Abstract

Due to the emerging resistance against classical β-lactam-based antibiotics, a growing number of bacterial infections has become harder to treat. This alarming tendency necessitates continued research on novel antibacterial agents. Many classes of β-lactam antibiotics are characterized by the presence of the 3-aminoazetidin-2-one core, which resembles the natural substrate of the target penicillin-binding proteins. In that respect, this Review summarizes the different synthetic pathways toward this key structure for the development of new antibacterial agents. The most extensively applied methods for 3-amino-β-lactam ring formation are discussed, in addition to a few less common strategies. Moreover, approaches to introduce the 3-amino substituent after ring formation are also covered.

Keywords: 3-amino-β-lactams; Staudinger synthesis; cyclization; cycloaddition; reactivity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Different classes of β‐lactam antibiotics.
Figure 2
Figure 2
Synthetic applications of 3‐amino‐β‐lactams to produce a broad variety of β‐lactam and non‐β‐lactam products.
Scheme 1
Scheme 1
Staudinger [2+2] cyclocondensation between ketenes 5 and imines 6.
Scheme 2
Scheme 2
Ketene generation by photolysis of chromium–carbene complexes 11 and münchnones 14.
Scheme 3
Scheme 3
Synthesis of 3‐amino‐β‐lactam 19 starting from acetyl chloride 16 and imine 17.
Figure 3
Figure 3
Dane salt 20.
Figure 4
Figure 4
Reagents for activating carboxylic acids in β‐lactam synthesis.
Scheme 4
Scheme 4
Asymmetric Staudinger synthesis using (4S)‐2‐oxo‐4‐phenyloxazolidin‐3‐ylacetyl chloride (23) and imines 24.
Scheme 5
Scheme 5
Asymmetric synthesis using N‐[bis(trimethylsilyl)methylidene]amines 28.
Scheme 6
Scheme 6
Asymmetric synthesis using camphorsultam‐derived ketenes.
Scheme 7
Scheme 7
Asymmetric induction by imines 36 derived from (1R)‐1‐phenyl‐ and (1R)‐1‐(1‐naphtyl)ethylamine.
Figure 5
Figure 5
Imines 3941 derived from chiral amines d‐glucosamine, 2‐amino‐1‐phenylpropane‐1,3‐diol and d‐threonine.
Scheme 8
Scheme 8
Asymmetric induction by imines 43 derived from d‐glyceraldehyde acetonide.
Scheme 9
Scheme 9
Asymmetric induction by imines 45 derived from O‐silyl‐protected α‐hydroxy aldehydes.
Figure 6
Figure 6
Imines derived from chiral aldehydes: nitrogen analogue 48 of d‐glyceraldehyde acetonide, α‐amino imines 49 and α,β‐epoxyimines 50.
Scheme 10
Scheme 10
Double asymmetric induction approach using chiral ketenes derived from 51 and chiral N‐substituted imines 52.
Scheme 11
Scheme 11
Double asymmetric induction approach using “matched” or “mismatched” chiral templates.
Scheme 12
Scheme 12
The catalytic, asymmetric, “umpolung” Staudinger reaction. Ts, p‐toluenesulfonyl; BQ, benzoylquinine (63).
Scheme 13
Scheme 13
Conversion of hexahydro‐s‐hydrazines 66 to monomeric formaldimines 67 by treatment with a Lewis acid.
Scheme 14
Scheme 14
Staudinger synthesis with dialkylhydrazones 69.
Scheme 15
Scheme 15
The cyclocondensation between α‐amino esters 71 and imines 73 or N‐(cyanomethyl)amines 74.
Scheme 16
Scheme 16
The Kinugasa cycloaddition between 3‐ethynyloxazolidin‐2‐ones 77 and nitrones 78.
Scheme 17
Scheme 17
The copper‐catalyzed conversion of phthalimido acetylene (83) and cyclic nitrones 84 to monocyclic β‐lactam 88.
Scheme 18
Scheme 18
N1−C4 cyclization of α‐amino‐β‐hydroxy hydroxamates 89.
Scheme 19
Scheme 19
Conversion of C‐fused β‐lactam 92 to monocyclic 3‐aminoazetidin‐2‐one 95.
Figure 7
Figure 7
Elimination products 97 and pyrrolidinone side products 98 of the cyclization of dipeptides 96, and aziridine side products 100 of the cyclization of N‐arylamides 99.
Scheme 20
Scheme 20
A Pummerer‐type rearrangement of tripeptide 101.
Scheme 21
Scheme 21
The ring‐closure‐induced ring opening of cyclic sulfamidate 105.
Scheme 22
Scheme 22
The Pd‐catalyzed amidation of amide 109.
Scheme 23
Scheme 23
N1−C2 cyclization of α,β‐diamino carboxylic acids and esters 112.
Scheme 24
Scheme 24
C3−C4 bond formation by oxidative coupling of amide 114.
Scheme 25
Scheme 25
Conversion of 3‐carboxy‐β‐lactam 117 to 3‐amino‐β‐lactam 118.
Scheme 26
Scheme 26
Conversion of 3‐hydroxy‐β‐lactams 119 to 3‐azido derivatives 121.
Scheme 27
Scheme 27
Different approaches to introduce the 3‐amino group starting from 3‐oxo‐β‐lactams 122.
Scheme 28
Scheme 28
Treatment of 3‐oxo‐β‐lactams 128 with secondary amines.
Scheme 29
Scheme 29
Bismuth‐nitrate‐catalyzed conversion of 3‐oxo‐β‐lactams 130 toward 3‐pyrrolyl‐β‐lactams 131.
Scheme 30
Scheme 30
Introduction of a 3‐amino group after lithium–halogen exchange.
Scheme 31
Scheme 31
Addition of N‐nucleophiles onto 3‐alkylidene‐β‐lactams 134.
Scheme 32
Scheme 32
Conversion of 3‐unsubstituted β‐lactams 136 to 3‐amino‐β‐lactams 138.
Scheme 33
Scheme 33
Simultaneous azide transfer and N−O bond cleavage during diazotization of β‐keto ester 139.
Scheme 34
Scheme 34
Addition of N‐nucleophiles to 3‐unsubstituted N‐tosyloxy‐β‐lactams 141.
Scheme 35
Scheme 35
Ugi reaction of α‐azido‐β‐amino acid 144, formaldehyde (145) and isocyanides 146.

References

    1. None
    1. Mehta P. D., Sengar N. P. S., Pathak A. K., Eur. J. Med. Chem. 2010, 45, 5541–5560; - PubMed
    1. Galletti P., Giacomini D., Curr. Med. Chem. 2011, 18, 4265–4283; - PubMed
    1. Arya N., Jagdale A. Y., Patil T. A., Yeramwar S. S., Holikatti S. S., Dwivedi J., Shishoo C. J., Jain K. S., Eur. J. Med. Chem. 2014, 74, 619–656; - PubMed
    1. L. Decuyper, M. Jukič, I. Sosič, A. Žulab, M. D′hooghe, S. Gobec, Med. Res. Rev 2017, 37, https://doi.org/10.1002/med.21443. - DOI - PubMed

LinkOut - more resources